Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats

被引:41
|
作者
Miyata, M [1 ]
Ito, M [1 ]
Sasajima, T [1 ]
Ohira, H [1 ]
Kasukawa, R [1 ]
机构
[1] Fukushima Med Univ, Sch Med, Dept Internal Med 2, Fukushima, Japan
关键词
5-hydroxytryptamine; interleukin; 6; MCI-90-42; pulmonary hypertension; serotonin; serotonin receptor; serotonin receptor antagonist; thromboembolic pulmonary hypertension;
D O I
10.1378/chest.119.2.554
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To determine the significance of serotonin in the pathogenesis of interleukin (IL) 6-induced pulmonary hypertension (IL-6-PH) in rats, the plasma serotonin concentrations, and the effects of a specific antagonist of the serotonin (5-hydroxytryptamine [5-HT]) receptor, 1-[o-(m-methoxyphenyl)ethyl]phenoxy]-3-(dimethylamino)-2-propyl hydrogen succinate hydrochloride (MCI) on the degree of pulmonary hypertension (PH) were investigated in MCI-treated IL-6-PH (IL-6-MCI-PH) rats. Measurements: The thickness of the media of small pulmonary arteries and the ratio of the weight of the right ventricle free wall (RV) to that of the left ventricle with the septum (LV + S) were measured as indexes of the degree of PH. Serotonin concentrations in plasma and in supernatants of cultured vascular smooth muscle cells (VSMCs) stimulated by IL-6 were measured by high-performance liquid chromatography. The amplification of DNA encoding the 5-HT receptor in the lung specimen and VSMCs was performed by polymerase chain reaction. Results: The degree of PH, as determined by the medial thickness of small pulmonary arteries, was significantly increased in IL-6-PH rats as compared with normal control rats (p < 0.05), and that in IL-6-MCI-PH rats was not significantly different from that in normal control rats. The RV/LV + S weight ratio in the IL-6-PH rats was significantly higher than that in normal control rats (p < 0.01). The RV/LV + S weight ratio in IL-6-MCI-PH rats was significantly lower than that in IL-6-PH rats (p < 0.01) and was not significantly different from that in normal control rats. The serotonin concentration was significantly higher in IL-6-PH rats than in normal control rats (p < 0.02), and the serotonin concentration in IL-6-MCI-PH rats was not significantly different from that in the normal control rats. The expression levels of the 5-HT receptor messenger RNA in the lung tissue tended to increase in IL-6-PH rats but was suppressed in IL-6-MCI-PH rats. IL-6 significantly increased the amount of serotonin released from VSMCs (p < 0.02). The expression of the 5-HT receptor messenger RNA was observed with IL-6 stimulation as was observed with serotonin stimulation in VSMCs. Conclusions: Serotonin receptor antagonists could be considered as potentially useful agents for the treatment of chronic thromboembolic PH, as well as for that of primary PH and PH associated with collagen vascular diseases.
引用
收藏
页码:554 / 561
页数:8
相关论文
共 50 条
  • [41] The co-regulators SRC-1 and SMRT are involved in interleukin-6-induced androgen receptor activation
    Qi Wang
    Hui Wang
    Qiang Ju
    Zhen Ding
    Xing Ge
    Qiao-Mei Shi
    Ji-Long Zhou
    Xiao-Long Zhou
    Jin-Peng Zhang
    Mei-Rong Zhang
    Hong-Min Yu
    Li-Chun Xu
    European Cytokine Network, 2016, 27 : 108 - 113
  • [42] Ectopic expression of membrane receptor interleukin-6 in pulmonary arterial hypertension
    Tu, Ly
    Phan, Carole
    Humbert, Marc
    Guignabert, Christophe
    M S-MEDECINE SCIENCES, 2018, 34 (10): : 765 - 768
  • [43] Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats
    Chen, SJ
    Chen, YF
    Meng, QC
    Durand, J
    Dicarlo, VS
    Oparil, S
    JOURNAL OF APPLIED PHYSIOLOGY, 1995, 79 (06) : 2122 - 2131
  • [44] THE ENDOTHELIN RECEPTOR ANTAGONIST BOSENTAN PREVENTS SHORT-TERM HYPOXIA-INDUCED PULMONARY-HYPERTENSION IN THE RATS
    CHEN, SJ
    CHEN, YF
    MENG, QC
    OPARIL, S
    CIRCULATION, 1994, 90 (04) : 151 - 151
  • [45] INTRAPARTUM TREATMENT OF PREECLAMPTIC HYPERTENSION BY KETANSERIN - A SEROTONIN RECEPTOR ANTAGONIST
    WEINER, CP
    GELFAN, R
    SOCOL, ML
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 149 (05) : 576 - 578
  • [46] CONTROL OF PREECLAMPTIC HYPERTENSION BY KETANSERIN, A NEW SEROTONIN RECEPTOR ANTAGONIST
    WEINER, CP
    SOCOL, ML
    VAISRUB, N
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 149 (05) : 496 - 500
  • [47] Cypermethrin inhibits interleukin-6-induced androgen receptor transactivation through signal transducer and activator of transcription 3
    Zhou, Ji-Long
    Ding, Zhen
    Ge, Xing
    Shi, Qiao-Mei
    Wang, Heng-Xue
    Chen, Gang
    Li, Meng-Xue
    Wang, Hui
    Ju, Qiang
    Wang, Qi
    Zhang, Jin-Peng
    Zhang, Mei-Rong
    Xu, Li-Chun
    TOXICOLOGY MECHANISMS AND METHODS, 2017, 27 (09) : 717 - 722
  • [48] Effect of serotonin receptor antagonist on phosphate excretion
    Gross, JM
    Berndt, TJ
    Knox, FG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2000, 11 (06): : 1002 - 1007
  • [49] The co-regulators SRC-1 and SMRT are involved in interleukin-6-induced androgen receptor activation
    Wang, Qi
    Wang, Hui
    Ju, Qiang
    Ding, Zhen
    Ge, Xing
    Shi, Qiao-Mei
    Zhou, Ji-Long
    Zhou, Xiao-Long
    Zhang, Jin-Peng
    Zhang, Mei-Rong
    Yu, Hong-Min
    Xu, Li-Chun
    EUROPEAN CYTOKINE NETWORK, 2016, 27 (04) : 108 - 113
  • [50] Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice
    Golembeski, SA
    West, J
    Tada, Y
    Fagan, KA
    CHEST, 2005, 128 (06) : 572S - 573S